Aurobindo Pharma gains 5% on acquisition of Sandoz's US business

The stock rallied 5% to Rs 732 on Thursday, extending its Wednesday's 2% gain on the BSE, after the company announced the acquisition of Sandoz's generic business in the US for $900 million.

from Latest News https://ift.tt/2Nqpk3a

Facebook Google Twitter More

• Pinterest
• Linkedin
• Tumblr

Posted by : Camera Guru 12:33 pm Tags : Latest News

Subscribe by Email

Follow Updates Articles from This Blog via Email